Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorBuket Kömürcü

About this trial

Ectopic pregnancy (EP) is defined as the implantation of a fertilized ovum outside the uterine cavity, most commonly in the fallopian tubes. EP is a potentially life-threatening condition due to the risk of tubal rupture and intra-abdominal bleeding. Management of ectopic pregnancy may involve medical or surgical treatment, often requiring hospitalization.

Following treatment and discharge, women may experience physical, emotional, and sexual health challenges. In addition, the need for effective contraception after ectopic pregnancy treatment is critical due to the risk of recurrent ectopic pregnancy and the potential teratogenic effects of treatment agents such as methotrexate. However, limited data are available regarding contraceptive intentions and sexual quality of life after ectopic pregnancy treatment in Türkiye.

This study aims to evaluate contraceptive intention and sexual quality of life in women treated for ectopic pregnancy and to examine the relationship between length of hospital stay, contraceptive intention, and sexual quality of life. Data will be collected using the Participant Information Form, the Contraceptive Intention Scale (CIS), and the Sexual Life Quality Scale-Women (SLQS-W). In addition, a reproductive health educational brochure will be provided to participants as part of post-treatment counseling.

Eligibility criteria

Qualifiers

Women admitted to the Obstetrics and Gynecology clinics at Izmir City Hospital,

Aged 18 years and older,

Diagnosed with ectopic pregnancy,

Able to read and write in Turkish,

Disqualifiers

Women undergoing infertility treatment,

Women requesting tubal ligation.

Trial design

Treatments tested in this trial

  • Reproductive Health Counseling and Educational Brochure

Treatment groups

102 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Buket Kömürcü

Lead sponsor

Ege University

Sponsor institution

Izmir City Hospital

Collaborator

Ege University

Collaborator